G 蛋白偶联受体的变构调节剂。
Allosteric Modulators of G Protein-Coupled Receptors.
机构信息
Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, 194223 St. Petersburg, Russia.
出版信息
Int J Mol Sci. 2022 Mar 8;23(6):2934. doi: 10.3390/ijms23062934.
Abstract
The G protein-coupled receptors (GPCRs) are the largest group of membrane receptor proteins that are targeted by more than 30% of drugs [...].
摘要
G 蛋白偶联受体（GPCRs）是最大的一类膜受体蛋白，超过 30%的药物以其作为靶点[... ]。
相似文献
1
Allosteric Modulators of G Protein-Coupled Receptors.G 蛋白偶联受体的变构调节剂。
Int J Mol Sci. 2022 Mar 8;23(6):2934. doi: 10.3390/ijms23062934.
2
Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug-Target Interactions.G 蛋白偶联受体的小分子变构调节剂：药物-靶标相互作用。
J Med Chem. 2019 Jan 10;62(1):24-45. doi: 10.1021/acs.jmedchem.7b01844. Epub 2018 Feb 26.
3
Strategies for the identification of allosteric modulators of G-protein-coupled receptors.G 蛋白偶联受体变构调节剂的鉴定策略。
Biochem Pharmacol. 2011 Mar 15;81(6):691-702. doi: 10.1016/j.bcp.2010.12.012. Epub 2010 Dec 22.
4
Structural Basis for Allosteric Modulation of Class B G Protein-Coupled Receptors.结构基础：B 类 G 蛋白偶联受体的别构调节。
Annu Rev Pharmacol Toxicol. 2020 Jan 6;60:89-107. doi: 10.1146/annurev-pharmtox-010919-023301. Epub 2019 Aug 27.
5
Endogenous allosteric modulators of G protein-coupled receptors.G蛋白偶联受体的内源性变构调节剂
J Pharmacol Exp Ther. 2015 May;353(2):246-60. doi: 10.1124/jpet.114.221606. Epub 2015 Feb 3.
6
Computational Advances for the Development of Allosteric Modulators and Bitopic Ligands in G Protein-Coupled Receptors.G蛋白偶联受体变构调节剂和双位点配体开发中的计算进展
AAPS J. 2015 Sep;17(5):1080-95. doi: 10.1208/s12248-015-9776-y. Epub 2015 May 5.
7
Allosteric modulators of rhodopsin-like G protein-coupled receptors: opportunities in drug development.视紫红质样 G 蛋白偶联受体的变构调节剂：药物开发的机遇。
Pharmacol Ther. 2012 Sep;135(3):292-315. doi: 10.1016/j.pharmthera.2012.06.002. Epub 2012 Jun 19.
8
Allosteric communication pipelines in G-protein-coupled receptors.G蛋白偶联受体中的变构通讯途径
Curr Opin Pharmacol. 2016 Oct;30:76-83. doi: 10.1016/j.coph.2016.07.010. Epub 2016 Aug 4.
9
Allosteric modulation of G-protein coupled receptors.G蛋白偶联受体的变构调节
Eur J Pharm Sci. 2004 Mar;21(4):407-20. doi: 10.1016/j.ejps.2003.11.007.
10
Allosteric modulators of G-protein-coupled receptors.G蛋白偶联受体的变构调节剂
Curr Opin Pharmacol. 2003 Oct;3(5):551-6. doi: 10.1016/s1471-4892(03)00107-3.
引用本文的文献
1
Allosteric Regulation of G-Protein-Coupled Receptors: From Diversity of Molecular Mechanisms to Multiple Allosteric Sites and Their Ligands.别构调节 G 蛋白偶联受体：从分子机制多样性到多个别构结合位点及其配体。
Int J Mol Sci. 2023 Mar 24;24(7):6187. doi: 10.3390/ijms24076187.
本文引用的文献
1
Search for Structural Basis of Interactions of Biogenic Amines with Human TAAR1 and TAAR6 Receptors.寻找生物胺与人 TAAR1 和 TAAR6 受体相互作用的结构基础。
Int J Mol Sci. 2021 Dec 25;23(1):209. doi: 10.3390/ijms23010209.
2
Living-Cell Diffracted X-ray Tracking Analysis Confirmed Internal Salt Bridge Is Critical for Ligand-Induced Twisting Motion of Serotonin Receptors.活细胞衍射 X 射线跟踪分析证实内部盐桥对于配体诱导的血清素受体扭曲运动至关重要。
Int J Mol Sci. 2021 May 17;22(10):5285. doi: 10.3390/ijms22105285.
3
Allosteric Modulation of GPCRs of Class A by Cholesterol.A 类 G 蛋白偶联受体的变构调节：胆固醇的作用。
Int J Mol Sci. 2021 Feb 16;22(4):1953. doi: 10.3390/ijms22041953.
4
Pharmacology of Free Fatty Acid Receptors and Their Allosteric Modulators.游离脂肪酸受体及其别构调节剂的药理学。
Int J Mol Sci. 2021 Feb 10;22(4):1763. doi: 10.3390/ijms22041763.
5
Dynamical Correlations Reveal Allosteric Sites in G Protein-Coupled Receptors.动态相关揭示 G 蛋白偶联受体中的变构位点。
Int J Mol Sci. 2020 Dec 27;22(1):187. doi: 10.3390/ijms22010187.
6
Comparative Study of the Steroidogenic Effects of Human Chorionic Gonadotropin and Thieno[2,3-D]pyrimidine-Based Allosteric Agonist of Luteinizing Hormone Receptor in Young Adult, Aging and Diabetic Male Rats.青年、老年和糖尿病雄性大鼠中 hCG 和噻吩并[2,3-d]嘧啶基促黄体生成素受体变构激动剂的甾体生成作用比较研究。
Int J Mol Sci. 2020 Oct 11;21(20):7493. doi: 10.3390/ijms21207493.
Zotero 插件